Shijiazhuang Yiling Pharmaceutical Co., Ltd.
Symbol: 002603.SZ
SHZ
19.58
CNYMarkedspris i dag
12.0881
P/E-forhold
0.2763
PEG Ratio
32.71B
MRK Cap
- 0.03%
DIV Udbytte
Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603-SZ) Årsregnskaber
Balance
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 8322.47 | 2422.7 | 1050.5 | 1554 | |||||||||||||||
balance-sheet.row.short-term-investments | 2554.79 | 518.4 | 55.3 | 217 | |||||||||||||||
balance-sheet.row.net-receivables | 11259.24 | 2699.6 | 2593.1 | 2102.4 | |||||||||||||||
balance-sheet.row.inventory | 9782.92 | 2021.8 | 1672.7 | 1580.3 | |||||||||||||||
balance-sheet.row.other-current-assets | 631.46 | 110.1 | 285.8 | 222.7 | |||||||||||||||
balance-sheet.row.total-current-assets | 29996.09 | 7254.2 | 5602.1 | 5459.4 | |||||||||||||||
balance-sheet.row.property-plant-equipment-net | 26574.19 | 6221.8 | 5745.5 | 4299.1 | |||||||||||||||
balance-sheet.row.goodwill | 228.47 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.intangible-assets | 3445.29 | 828 | 897.9 | 736.6 | |||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 3673.77 | 828 | 897.9 | 736.6 | |||||||||||||||
balance-sheet.row.long-term-investments | 4655.45 | 830.5 | -54.3 | -216 | |||||||||||||||
balance-sheet.row.tax-assets | 820.62 | 279.9 | 117 | 137.8 | |||||||||||||||
balance-sheet.row.other-non-current-assets | 4451.29 | 921.8 | 596.6 | 1075.3 | |||||||||||||||
balance-sheet.row.total-non-current-assets | 40175.32 | 9081.9 | 7302.7 | 6032.9 | |||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.total-assets | 70171.42 | 16336.1 | 12904.8 | 11492.3 | |||||||||||||||
balance-sheet.row.account-payables | 10015.9 | 2060.8 | 1621.2 | 1188.4 | |||||||||||||||
balance-sheet.row.short-term-debt | 3422.6 | 656.3 | 513.9 | 270.2 | |||||||||||||||
balance-sheet.row.tax-payables | 1098.62 | 474 | 123.2 | 133.9 | |||||||||||||||
balance-sheet.row.long-term-debt-total | 1455.8 | 215.1 | 513 | 10.5 | |||||||||||||||
Deferred Revenue Non Current | 1400.88 | 335 | 357.8 | 328.1 | |||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 263.2 | - | - | - | |||||||||||||||
balance-sheet.row.other-current-liab | 1781.83 | 1027.3 | 216.3 | 28.3 | |||||||||||||||
balance-sheet.row.total-non-current-liabilities | 3119.87 | 555.7 | 872.2 | 330.1 | |||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.capital-lease-obligations | 54.95 | 15 | 12.5 | 10.5 | |||||||||||||||
balance-sheet.row.total-liab | 23563.79 | 5405.8 | 3832.7 | 2569 | |||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.common-stock | 6682.82 | 1670.7 | 1670.7 | 1203.7 | |||||||||||||||
balance-sheet.row.retained-earnings | 26853.23 | 5989.2 | 4306.2 | 4324.4 | |||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 8524.94 | 989 | 808.9 | 640.9 | |||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 4566.63 | 2283.3 | 2283.3 | 2750.3 | |||||||||||||||
balance-sheet.row.total-stockholders-equity | 46627.62 | 10932.2 | 9069.1 | 8919.3 | |||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 70171.42 | 16336.1 | 12904.8 | 11492.3 | |||||||||||||||
balance-sheet.row.minority-interest | -19.99 | -1.9 | 3 | 4.1 | |||||||||||||||
balance-sheet.row.total-equity | 46607.63 | 10930.3 | 9072.2 | 8923.4 | |||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 70171.42 | - | - | - | |||||||||||||||
Total Investments | 7210.24 | 1348.9 | 1 | 1 | |||||||||||||||
balance-sheet.row.total-debt | 4878.39 | 871.4 | 1026.9 | 270.2 | |||||||||||||||
balance-sheet.row.net-debt | -889.29 | -1032.8 | 31.6 | -1066.8 |
Pengestrømsopgørelse
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 2706.16 | 2356.8 | 1341.6 | 1214.9 | |||||||||||||||
cash-flows.row.depreciation-and-amortization | 121.87 | 451.5 | 362.9 | 268.2 | |||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -158.7 | 20.1 | -67.7 | |||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 158.7 | -20.1 | 67.7 | |||||||||||||||
cash-flows.row.change-in-working-capital | -1179.67 | 547.8 | -1309.7 | 24.8 | |||||||||||||||
cash-flows.row.account-receivables | -831.66 | -831.7 | -1280.3 | -668.7 | |||||||||||||||
cash-flows.row.inventory | -348.01 | -348 | -104.7 | -364.9 | |||||||||||||||
cash-flows.row.account-payables | 22.82 | 1886.2 | 55.1 | 1126.1 | |||||||||||||||
cash-flows.row.other-working-capital | -22.82 | -158.7 | 20.1 | -67.7 | |||||||||||||||
cash-flows.row.other-non-cash-items | 245.91 | 131.6 | 133.9 | 78.3 | |||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 1894.27 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -246.9 | -214 | -673.6 | -1144.8 | |||||||||||||||
cash-flows.row.acquisitions-net | -628.54 | 0.4 | 2.4 | 1145.1 | |||||||||||||||
cash-flows.row.purchases-of-investments | -5902.36 | -3461.9 | -451 | -2853.3 | |||||||||||||||
cash-flows.row.sales-maturities-of-investments | 4047.54 | 1680.7 | 616.6 | 2957.6 | |||||||||||||||
cash-flows.row.other-investing-activites | 0.36 | 0 | -1.2 | -1144.8 | |||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -2729.91 | -1994.8 | -506.8 | -1040.2 | |||||||||||||||
cash-flows.row.debt-repayment | -1250 | -2200 | -1469.9 | -270 | |||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.dividends-paid | -413.64 | -282.7 | -1220.1 | -244.1 | |||||||||||||||
cash-flows.row.other-financing-activites | 1321.67 | 1845.7 | 2387.9 | 490.8 | |||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -341.96 | -637 | -302.1 | -23.3 | |||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0.28 | 1.2 | -0.5 | -2 | |||||||||||||||
cash-flows.row.net-change-in-cash | -663.1 | 857.2 | -280.7 | 520.8 | |||||||||||||||
cash-flows.row.cash-at-end-of-period | 5395.81 | 1810.7 | 953.5 | 1234.2 | |||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 6058.9 | 953.5 | 1234.2 | 713.4 | |||||||||||||||
cash-flows.row.operating-cash-flow | 1894.27 | 3487.7 | 528.7 | 1586.2 | |||||||||||||||
cash-flows.row.capital-expenditure | -246.9 | -214 | -673.6 | -1144.8 | |||||||||||||||
cash-flows.row.free-cash-flow | 1647.37 | 3273.8 | -144.9 | 441.4 |
Resultatopgørelse række
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 13161.66 | 12532.8 | 10116.8 | 8782.5 | |||||||||||||||
income-statement-row.row.cost-of-revenue | 4867.04 | 4540.6 | 3681 | 3118.4 | |||||||||||||||
income-statement-row.row.gross-profit | 8294.62 | 7992.3 | 6435.8 | 5664.1 | |||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||
income-statement-row.row.research-development | 1074.04 | - | - | - | |||||||||||||||
income-statement-row.row.selling-general-administrative | 235.76 | - | - | - | |||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 3177.48 | - | - | - | |||||||||||||||
income-statement-row.row.other-expenses | 505.39 | 576.9 | 366.6 | 323 | |||||||||||||||
income-statement-row.row.operating-expenses | 4982.24 | 5025.8 | 4758.7 | 4179.2 | |||||||||||||||
income-statement-row.row.cost-and-expenses | 9849.29 | 9566.4 | 8439.7 | 7297.6 | |||||||||||||||
income-statement-row.row.interest-income | 14.34 | 12.9 | 20.4 | 7 | |||||||||||||||
income-statement-row.row.interest-expense | 36.75 | 33.8 | 34 | 3.8 | |||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 3177.48 | - | - | - | |||||||||||||||
income-statement-row.row.total-other-income-expensenet | -20.99 | -48.9 | -15.4 | -15.6 | |||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||
income-statement-row.row.other-operating-expenses | 505.39 | 576.9 | 366.6 | 323 | |||||||||||||||
income-statement-row.row.total-operating-expenses | -20.99 | -48.9 | -15.4 | -15.6 | |||||||||||||||
income-statement-row.row.interest-expense | 36.75 | 33.8 | 34 | 3.8 | |||||||||||||||
income-statement-row.row.depreciation-and-amortization | 100.71 | 546.1 | 448.6 | 329.5 | |||||||||||||||
income-statement-row.row.ebitda-caps | 3303.32 | - | - | - | |||||||||||||||
income-statement-row.row.operating-income | 3202.61 | 2829.6 | 1569.1 | 1438 | |||||||||||||||
income-statement-row.row.income-before-tax | 3181.62 | 2780.6 | 1553.7 | 1422.5 | |||||||||||||||
income-statement-row.row.income-tax-expense | 482.98 | 423.8 | 212.1 | 207.5 | |||||||||||||||
income-statement-row.row.net-income | 2706.16 | 2361.8 | 1343.9 | 1218.7 |
Ofte stillede spørgsmål
Hvad er Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ) samlede aktiver?
Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ) samlede aktiver er 16336112689.000.
Hvad er virksomhedens årlige omsætning?
Den årlige omsætning er 4639721722.000.
Hvad er virksomhedens profitmargin?
Virksomhedens profitmargin er 0.630.
Hvad er virksomhedens frie pengestrøm?
Det frie cash flow er 0.986.
Hvad er virksomhedens nettoprofitmargin?
Nettofortjenstmargenen er 0.206.
Hvad er firmaets samlede omsætning?
Den samlede omsætning er 0.243.
Hvad er Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ) nettoresultat (nettoindkomst)?
Nettoresultatet (nettoindkomsten) er 2361804714.000.
Hvad er virksomhedens samlede gæld?
Den samlede gæld er 871449540.000.
Hvad er tallet for driftsudgifter?
Driftsudgifterne er 5025828583.000.
Hvad er firmaets likviditet?
Virksomhedens likviditet er 1072618858.000.